Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Theravance Inc

+ Add to Watchlist

THRX:US

16.6200 USD 0.0300 0.18%

As of 20:10:00 ET on 05/26/2015.

Snapshot for Theravance Inc (THRX)

Open: 16.4900 Day's Range: 16.3100 - 16.6900 Volume: 399,772
Previous Close: 16.6500 52wk Range: 10.5800 - 31.8000 1-Yr Rtn: -25.15%

Stock Chart for THRX

No chart data available.
  • THRX:US 16.6100
  • 1D
  • 1M
  • 1Y
16.6500
Interactive THRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for THRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6000
Est. EPS (USD) (12/2015) -0.1280
Est. PEG Ratio -
Market Cap (M USD) 1,942.42
Shares Outstanding (M) 116.87
30 Day Average Volume 627,931
Price/Book (mrq) -
Price/Sale (ttm) 117.8205
Dividend Indicated Gross Yield 6.02%
Cash Dividend (USD) 0.2500
Dividend Ex-Date 06/10/2015
5 Year Dividend Growth -
Next Earnings Announcement 08/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for THRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for THRX

Theravance Inc., is a biopharmaceutical company. The Company develops small molecule medicines for respiratory disease, bacterial infections, and gastrointestinal disorders.

Michael W AguiarPresident/CEOEric D'EsparbesSenior VP/CFO
George B AbercrombieSenior VP:Corporate PartnershipsTheodore J WitekSenior VP:Corporate Partnerships
More Company Profile & Key Executives for THRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil